10 News First Discusses Canfield’s VECTRA® WB360 whole-body imaging system, and ongoing melanoma research in Australia with Prof. H Peter Soyer
University of Queensland’s Prof. H Peter Soyer discusses Canfield’s VECTRA WB360 and its role in expanding Australian melanoma research with 10 News First. Researchers plan to create a database of over 100,000 clinically-accessible VECTRA WB360 patient images, enhancing melanoma screening, early diagnosis, and long-term skin surveillance. The system’s presence at multiple locations in Australia is possible as part of a AUS $10 million grant from the Australian Cancer Research Foundation, as they are using the DermaGraphix advanced body mapping technology to combat the nation’s high rate of melanoma. The VECTRA WB360 captures cross polarized and non-polarized images to create a precise 3D body map of the patient. This 3D body map provides clinicians and researchers the ability to identify changes in suspicious lesions on the surface of the skin over time.
Recent News in In The Media
- Advancing Skin Screenings: Dr. Charles E. Mount III and Director Howard Edington, MD Discuss VECTRA® WB360 at AHN Cancer Institute with CBS News
- Dr. Robyn Siperstein, M.D., discusses Canfield’s revolutionary AI & AR technology and its role in consultations in MedEsthetics Magazine
- Canfield’s VECTRA® WB360 recently installed at Allegheny Health Network Cancer Institute
- Dr. Sherina Balaratnam discusses with Francesca Ogiermann-White why Canfield’s VISIA® is an essential part of all her consultations
Most Recent News
- Advancing Skin Screenings: Dr. Charles E. Mount III and Director Howard Edington, MD Discuss VECTRA® WB360 at AHN Cancer Institute with CBS News
- National Doctors’ Day, Spotlighting Glynis Ablon, MD, FAAD
- Dr. Robyn Siperstein, M.D., discusses Canfield’s revolutionary AI & AR technology and its role in consultations in MedEsthetics Magazine
- VISIA®’s 5th Consecutive Win as Favorite Diagnostic Tool in Dermascope’s Aestheticians’ Choice Awards!